21 July 2026

Avance Clinical and Dongguk University Establish Strategic Partnership to Develop Future Clinical Research Talent

Avance Clinical and Dongguk University Establish Strategic Partnership to Develop Future Clinical Research Talent

Seoul, South Korea — 21 July 2026

The Department of Pharmaceutical and Bio-Industry, Graduate School of Dongguk University, and Avance Clinical — an Australian-headquartered global Clinical Research Organization (CRO) with a growing presence in Asia — have entered into a Memorandum of Understanding (MOU). The agreement strengthens collaboration between industry and academia and supports the development of future talent in the pharmaceutical and biotechnology sectors.

Read more

What the Partnership Covers

The partnership is designed to create practical education and internship opportunities aligned with the evolving needs of the pharmaceutical and biotechnology industry. Through the collaboration, both organizations will:

  • Develop industry-focused educational programs
  • Provide hands-on training experiences
  • Foster innovation through closer engagement between academia and industry

Practical Training at Avance Clinical’s Korea Office

As part of the initiative, graduate students from Dongguk University will have the opportunity to take part in practical training placements at Avance Clinical’s Korea office. The program is designed to expose students to:

  • Clinical operations
  • Global clinical trial execution
  • Real-world industry practices, through mentoring and training from experienced professionals

Why This Matters for Korea’s Life Sciences Sector

The collaboration is expected to contribute to the development of highly skilled clinical research professionals while establishing a long-term talent pipeline for the life sciences industry. It is also expected to:

  • Strengthen relationships between industry and academia
  • Enhance awareness of clinical research career opportunities among future professionals
  • Support Avance Clinical’s ongoing engagement with Korean academic institutions, researchers, and biotechnology organizations

Leadership Behind the Initiative

The university initiative is led by Professor Kyoung-Hee Kwon, Department Head and Program Director of the Department of Pharmaceutical and Bio-Industry at Dongguk University. Professor Kwon is widely recognized for her contributions to pharmaceutical management, regulatory science, and industry-academic collaboration in South Korea.

Executive Commentary

Joe Taouk

Joe Taouk, Vice President, Global Project Delivery, Avance Clinical: “This partnership reflects our shared commitment to developing future talent and strengthening collaboration between academia and industry.”

Jessica Han

Jessica Han, Director of Asian Operations and Country Head of South Korea, Avance Clinical: “By providing practical training and industry exposure, we aim to help prepare the next generation of clinical research professionals while contributing to the continued growth of Korea’s life sciences ecosystem.”

Frequently
Asked
Questions

It is a Memorandum of Understanding (MOU) between Avance Clinical and the Department of Pharmaceutical and Bio-Industry, Graduate School of Dongguk University, aimed at strengthening industry-academia collaboration and developing future clinical research talent.

Graduate students will have the opportunity to participate in practical training placements at Avance Clinical’s Korea office, gaining exposure to clinical operations, global clinical trial execution, and real-world industry practices through mentoring from experienced professionals.

Professor Kyoung-Hee Kwon, Department Head and Program Director of the Department of Pharmaceutical and Bio-Industry, leads the university’s side of the initiative. She is recognized for her work in pharmaceutical management, regulatory science, and industry-academic collaboration in South Korea.

The partnership supports Avance Clinical’s ongoing commitment to expanding engagement with Korean academic institutions, researchers, and biotechnology organizations, while helping build a long-term talent pipeline for the life sciences industry.

Avance Clinical is a full-service, Australian-headquartered global Contract Research Organization (CRO) servicing international biotechs across North America, Europe, Asia Pacific, and China. It specializes in early-phase and First-in-Human studies across more than 250 indications, as well as Oncology, Renal, Metabolic, and Central Nervous System trials. Avance Clinical has partnered with more than 700 emerging biotech companies and was named the 2026 Frost & Sullivan Global Company of the Year in the Biotech CRO industry.

Related Articles